ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial

Jong, P.G. de; Quenby, S.; Bloemenkamp, K.W.M.; Braams-Lisman, B.A.M.; Bruin, J.P. de; Coomarasamy, A.; ... ; Middeldorp, S. (2015)

Article / Letter to editor

• Recurrent miscarriage
• Pregnancy complications
• Fetal death
• Thrombophilia
• Anticoagulants
• Aspirin
• Low-molecular-weight-heparin

• All authors: Jong, P.G. de; Quenby, S.; Bloemenkamp, K.W.M.; Braams-Lisman, B.A.M.; Bruin, J.P. de; Coomarasamy, A.; David, M.; DeSancho, M.T.; Heijden, O.W.H. van der; Hoek, A.; Hutten, B.A.; Jochmans, K.; Koks, C.A.M.; Kuchenbecker, W.K.H.; Mol, B.J.; Torrance, H.L.; Scheepers, H.C.J.; Stephenson, M.D.; Verhoeve, H.R.; Visser, J.; Vries, J.I.P. de; Goddijn, M.; Middeldorp, S.
• Date: 2015-05-07
• Journal: Trials
• Volume: 16
• DOI: doi:10.1186/s13063-015-0719-9